Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Rises By 116.0%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 52,500 shares, a growth of 116.0% from the October 15th total of 24,300 shares. Based on an average daily trading volume, of 109,800 shares, the short-interest ratio is currently 0.5 days.

Tevogen Bio Trading Up 31.3 %

Shares of Tevogen Bio stock opened at $0.07 on Wednesday. The business’s 50 day moving average price is $0.04 and its 200 day moving average price is $0.03. Tevogen Bio has a one year low of $0.01 and a one year high of $0.28.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.